title: Roles of plasma membrane-associated sialidase NEU3 in human cancers.
abstract: Altered sialylation of glycosphingolipids is observed in cancer as a ubiquitous phenotype, leading to the appearance of tumor-associated antigens, aberrant adhesion and disturbance of transmembrane signaling. To understand the pathological significance of aberrant alterations of gangliosides in cancer, our studies have been focused on sialidase, which is responsible for the removal of sialic acids from glycoproteins and glycolipids. Among human sialidases so far identified, sialidase NEU3 is a key enzyme for ganglioside degradation because of its uniqueness both in its localization in the plasma membrane and in specifically hydrolyzing gangliosides. NEU3 is markedly up-regulated in many types of cancers including colon and renal carcinomas and suppresses apoptosis of cancer cells. The present paper briefly summarizes our recent results on the sialidase alterations and their significance in cancer. NEU3 is indeed closely related to malignancy and thus may be a potential target for cancer diagnosis and therapy.
authors.affiliation: Biochemistry Division, Miyagi Cancer Center Research Institute, 47-1 Nodayama, Medeshima-shiode, Natori, Miyagi, 981-1293, Japan. miyagi-ta173@pref.miyagi.jp
authors.forename: Taeko
authors.initials: T
authors.lastname: Miyagi
authors.forename: Tadashi
authors.initials: T
authors.lastname: Wada
authors.forename: Kazunori
authors.initials: K
authors.lastname: Yamaguchi
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D002292:Carcinoma, Renal Cell / Q000201:enzymology; D021941:Caveolae / Q000187:drug effects / Q000201:enzymology; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D002465:Cell Movement / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003110:Colonic Neoplasms / Q000201:enzymology; D004789:Enzyme Activation / Q000187:drug effects; D005732:Gangliosides / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D015850:Interleukin-6 / Q000494:pharmacology; D007680:Kidney Neoplasms / Q000201:enzymology; D008954:Models, Biological; D009369:Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D009439:Neuraminidase / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects; D015854:Up-Regulation / Q000187:drug effects; D018631:ras Proteins / Q000378:metabolism
chemical_list: D005732:Gangliosides; D015850:Interleukin-6; C465436:Neu3 protein, human; D009439:Neuraminidase; D018631:ras Proteins